ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the ε4 allele in Hungarian Alzheimer's dementia population

Neurochemical Research

Volumn 30, Issue 5, 2005, Pages 591-596

  Juhász, Anna ^a   Palotás, András ^a   Janka, Zoltán ^a   Rimanóczy, Ágnes ^a   Palotás, Miklós ^a   Bódi, Nikoletta ^a   Boda, Krisztina ^a   Zana, Marianna ^a   Vincze, Gábor ^b   Kálmán, János ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Pandy Kalman County Hospital   (Hungary)

Author keywords

Alzheimer's disease; ApoE promoter; Apolipoprotein E; Genetic risk factor; Hungarian population

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; EUROPE; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; FEMALE; HETEROZYGOTE DETECTION; HUMANS; HUNGARY; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 23944523570     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-005-2745-6     Document Type: Article

References (39)

1. G. Utermann M. Hees A. Steinmetz 1997 Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man Nature 269 604 647
2. J. Poirier 2000 Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism Ann. NY Acad. Sci 924 81 90
3. M. G. Martinoli J. Q. Trojanowski M. L. Schmidt S. E. Arnold T. M. Fujiwara V. M. Lee H. Hurtig J. P. Julien C. Clark 1995 Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia Acta Neuropathol 90 239 243
4. M. Shibata S. Yamada S. R. Kumar M. Calero J. Bading B. Frangione D. M. Holtzman C. A. Miller D. K. Strickland J. Ghiso B. V. Zlokovic 2000 Clearance of Alzheimer's amyloid-β (1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier J. Clin. Invest 106 1489 1499
5. D. M. Holtzman 2001 Role of ApoE/Aβ interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy J. Mol. Neurosci 17 147 155
6. A. M. Saunders 2000 Apolipoprotein E and Alzheimer disease: An update on genetic and functional analyses J. Neuropathol. Exp. Neurol 59 751 758
7. A. M. Saunders K. Schmader J. C. S. Breitner M. D. Benson B. T. Brown L Goldfarb D Goldgaber M. G. Manwaring H. M. Szymanski N McCown K. C. Dole D. E. Schmechel W. J. Strittmatter M. A. Pericak-Vance A. D. Roses 1993 Apolipoprotein E4 allele distributions in late onset Alzheimer's disease and in other amyloid-forming diseases Lancet 342 710 711
8. M. J. Bullido M. J. Artiga M. Recuero I. Sastre M. A. Garcia J. Aldudo C. Lendon S. W. Han J. C. Morris A. Frank J. Vazquez A. Goate F. Valdivieso 1998 A polymorphism in the regulatory region of ApoE associated with risk for Alzheimer's dementia Nat. Genet 18 69 71
9. M. J. Artiga M. J. Bullido I. Sastre M. Recuero M. A. Garcia J. Aldudo J. Vazquez F. Valdivieso 1998 Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein FEBS Lett 421 105 108
10. J. M. Taylor S. Lauer N Elshourbagy C Reardon E Taxman D Walker D Chang Y. K. Paik 1987 Structure and evolution of human apolipoprotein genes: Identification of regulatory elements of the human apolipoprotein E gene Ciba Found. Symp 130 70 86
11. G. Roks M. Cruts J. J. Houwing-Duistermaat B. Dermaut S. Serneels L. M. Havekes A. Hofman M. M. Breteler C. Van Broeckhoven C. M. Van Duijn 2002 Effect of the ApoE -491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study Am. J. Med. Genet 114 570 573
12. S. M. Laws E. Hone K. Taddei C. Harper B. Dean C. McClean C. Masters N. Lautenschlager S. E. Gandy R. N. Martins 2002 Variation at the ApoE -491 promoter locus is associated with altered brain levels of apolipoprotein E Mol. Psychiatr 7 886 890
13. K. R. Bales T. Verina R. C. Dodel Y. Du L. Altstiel M Bender P. Hyslop E. M. Johnstone S. P. Little D. J. Cummins P. Piccardo B. Ghetti S. M. Paul 1997 Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition Nat. Genet 17 263 264
14. P. L. Richey S. L. Siedlak M. A. Smith G. Perry 1995 Apolipoprotein E interaction with neurofibrillary tangles and senile plaques in Alzheimer disease: Implications for disease pathogenesis Biochem. Biophys. Res. Commun 208 657 663
15. H. Toji H. Maruyama K. Sasaki S. Nakamura H. Kawakami 1999 Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population Neurosci. Lett 259 56 58
16. D. M. Hallman E. Boerwinkle N. Saha C. Sandholzer H. J. Menzel A. Császár G. Utermann 1991 The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations Am. J. Hum. Genet 49 338 349
17. G. McKhann D. Drachman M. Folstein R. Katzman D. Price E. M. Stadlan 1984 Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 939 944
18. M. F. Folstein S. E. Folstein P. R. McHugh 1975 "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J. Psychiatr. Res 12 189 198
19. K.E. Davies 1986 Human genetic diseases. A practical approach IRL Press Oxford
20. J. Kálmán A. Juhász A. Császár A. Kanka E. Maglóczky K. Bencsik Z. Janka I. Raskó 1997 Apolipoprotein E allele frequencies in patients with late-onset sporadic Alzheimer's dementia in Hungary Acta Neurol. Scand 95 56 59
21. J. C. Wang J. M. Kwon P. Shah J. C. Morris A. Goate 2000 Effect of ApoE genotype and promoter polymorphism on risk of Alzheimer's disease Neurology 55 1644 1649
22. E. B. Wilson 1927 Probable inference, the law of succestion and statistical inference J. Am. Stat. Assoc 22 209 211
23. E. H. Corder A. M. Saunders W. J. Strittmatter D. E. Schmechel P. C. Gaskell G. W. Small A. D. Roses J. L. Haines M. A. Pericak-Vance 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 921 923
24. J. Hardy R. Crook G. Prihar G. Roberts R. Raghavan R. Rerrz 1994 Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease Neurosci. Lett 182 1 2
25. D. B. Jordan N. R. Relkin L. D. Ravdin A. R. Jacob A. Bennett S. Gandy 1997 Apolipoprotein E epsilon4 associated with chronic traumatic brain injury and boxing JAMA 278 136 140
26. D. C. Rubinsztein C. S. Hanlon R. M. Irving S. Goodburn D. G. Evans H. Kellar-Wood J. H. Xuereb O. Bandmann A. E. Harding 1994 Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease Mol. Cell. Probe 8 519 525
27. J. Kálmán A. Juhász A. Császár A. Kanka Á. Rimanóczy Z. Janka I. Raskó 1998 Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population Acta Neurol. Scand 98 166 168
28. C. J. Hu S. M. Sung H. C. Liu W. C. Hsu L. S. Lee C. C. Lee C. H. Tsai J. G. Chang 2000 Genetic risk factors of sporadic Alzheimer's disease among Chinese in Taiwan J. Neurol. Sci 181 127 131
29. M. Ruhlen 1987 A guide to the world's languages. Vol. 1: Classification Stanford University Press Stanford,, CA
30. R. M. Harding R. R. Sokal 1988 Classification of the European language families by genetic distance Proc. Natl. Acad. Sci. USA 85 9370 9372
31. R. T. Perry J. S. Collins L. E. Harrell R. T. Acton R. C. Go 2001 Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls Am. J. Med. Genet 105 332 342
32. J. Thome J. C. Gewirtz N. Sakai V. Zachariou P. Retz-Junginger W. Retz R. S. Duman M. Rosler 1999 Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase Neurosci Lett 274 37 40
33. L. Chen L. Baum H. K. Ng L. Y. Chan I. Sastre M. J. Artiga F. Valdivieso M. J. Bullido H. F. Chiu C. P. Pang 1999 Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease Neurosci Lett 269 173 177
34. L. Zurutuza P. Verpillat G. Raux D. Hannequin M. Puel S. Belliard A. Michon Y. Pothin A. Camuzat C. Penet C. Martin A. Brice D. Campion F. Clerget-Darpoux T. Frebourg 2000 ApoE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population Eur. J. Hum. Genet 8 713 716
35. R. Scacchi G. Gambina M. C. Martini M. Ruggeri G. Ferrari M. Silvestri R. Schiavon R. M. Corbo 2001 Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasma lipidic pattern Dement. Geriatr. Cogn. Disord 12 63 68
36. V. M. Casadei C. Ferri F. Veglia A. Gavazzi G. Salani M. Cattaneo S. Sorbi G. Annoni F. Licastro C. Mariani M. Franceschi L. M. Grimaldi 1999 ApoE -491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease Neurology 53 1888 1889
37. J. C. Lambert L. Araria-Goumidi L. Myllykangas C. Ellis J. C. Wang M. J. Bullido J. M. Harris M. J. Artiga D. Hernandez J. M. Kwon B. Frigard R. C. Petersen A. M. Cumming F. Pasquier I. Sastre P. J. Tienari A. Frank R. Sulkava J. C. Morris D. Clair D. M. Mann F. Wavrant-DeVrieze M. Ezquerra-Trabalon P. Amouyel J. Hardy M. Haltia F. Valdivieso A. M. Goate J. Perez-Tur C. L. Lendon M. C. Chartier-Harlin 2002 Contribution of ApoE promoter polymorphisms to Alzheimer's disease risk Neurology 59 59 66
38. T. Town D. Paris D. Fallin R. Duara W. Barker M. Gold F. Crawford M. Mullan 1998 The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: Independent risk and linkage disequilibrium with the known ApoE polymorphism Neurosci. Lett 252 95 98
39. S. Helisalmi M. Hiltunen P. Valonen A. Mannermaa A. M. Koivisto M. Lehtovirta M. Ryynanen H. J. Soininen 1999 Promoter polymorphism (-491A/T) in the ApoE gene of Finnish Alzheimer's disease patients and control individuals Neurology 246 821 824